Cargando…
Effects of long-term macrolide therapy at low doses in stable COPD
Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth largest fatal disease in the world, and is expected to rise to third place by 2020. Frequent acute exacerbations lead to increased mortality. Some suggestions for prophylactic use of macrolides in preventing COPD exacer...
Autores principales: | Cao, Yueqin, Xuan, Shurui, Wu, Yunhui, Yao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572718/ https://www.ncbi.nlm.nih.gov/pubmed/31354258 http://dx.doi.org/10.2147/COPD.S205075 |
Ejemplares similares
-
Low-dose, long-term macrolide therapy in asthma: An overview
por: Hatipoğlu, Umur, et al.
Publicado: (2004) -
The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
por: Nakamura, Kazunori, et al.
Publicado: (2023) -
The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
por: Ryu, Gwanghui, et al.
Publicado: (2023) -
Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases
por: Sun, Jialiang, et al.
Publicado: (2021) -
Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis
por: Cui, Yanan, et al.
Publicado: (2018)